Interpreting very low Mycobacterium tuberculosis detected on Xpert Mycobacterium tuberculosis/rifampicin

被引：6

作者：

Ajbani, Kanchan ^{[1
]}

Naik, Swapna ^{[1
]}

Kazi, Mubin ^{[1
]}

Shetty, Anjali ^{[1
]}

Rodrigues, Camilla ^{[1
]}

机构：

[1] PD Hinduja Hosp & Med Res Ctr, Dept Microbiol, Veer Savarkar Marg, Mumbai 400016, Maharashtra, India

来源：

LUNG INDIA | 2019年 / 36卷 / 06期

关键词：

Cartridge-based nucleic acid amplification test; pyrosequencing; rpoB; tuberculosis; Xpert Mycobacterium tuberculosis/rifampin; MTB/RIF; ASSAY;

D O I：

10.4103/lungindia.lungindia_463_18

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

The development and rollout of the Xpert (R) Mycobacterium tuberculosis/rifampicin assay for the GeneXpert platform is considered an important breakthrough in the fight against tuberculosis. Xpert though robust is known to have issues that occur with very low load of tuberculosis detection, wherein it is recommended to confirm resistance if resistance is not suspected using another genotypic test.

引用

页码：555 / 557

页数：3

共 50 条

[11] Xpert MTB/RIF assay for rapid detection of Mycobacterium tuberculosis and rifampicin resistance
Bhattacharyya, Debajyoti
Agarwal, A.
Barthwal, M. S.
Katoch, C. D. S.
EUROPEAN RESPIRATORY JOURNAL, 2012, 40
[12] Xpert Mycobacterium tuberculosis/Rifampicin-Detected Rifampicin Resistance is a Suboptimal Surrogate for Multidrug-resistant Tuberculosis in Eastern Democratic Republic of the Congo: Diagnostic and Clinical Implications
Bisimwa, Bertin C.
Nachega, Jean B.
Warren, Robin M.
Theron, Grant
Metcalfe, John Z.
Shah, Maunank
Diacon, Andreas H.
Sam-Agudu, Nadia A.
Yotebieng, Marcel
Bulabula, Andre N. H.
Katoto, Patrick D. M. C.
Chirambiza, Jean-Paul
Nyota, Rosette
Birembano, Freddy M.
Musafiri, Eric M.
Byadunia, Sifa
Bahizire, Esto
Kaswa, Michel K.
Callens, Steven
Kashongwe, Zacharie M.
CLINICAL INFECTIOUS DISEASES, 2021, 73 (02) : E362 - E370
[13] MYCOBACTERIUM-TUBERCULOSIS RESISTANCE TO RIFAMPICIN
FERNANDEZGUERRERO, ML
POSADADUENAS, R
FERNANDEZLAZCANO, F
PADILLAMANZUCO, JM
REVISTA CLINICA ESPANOLA, 1978, 150 (06): : 357 - 359
[14] MECHANISMS OF RIFAMPICIN RESISTANCE IN MYCOBACTERIUM TUBERCULOSIS
Mahanta, Sailendra Kumar
Peddinti, Bhavani
INTERNATIONAL JOURNAL OF LIFE SCIENCE AND PHARMA RESEARCH, 2020, : 49 - 53
[15] Detection of mycobacterium tuberculosis and rifampicin resistance with Xpert® MTB/RIF analysis in a tertiary hospital
Zarras, C.
Zarras, K.
Pyrpasopoulou, A.
Michailidou, C.
Mpani, K.
Soukiouroglou, P.
Mpiska, M.
Voulgaridis, A.
Vagdatli, E.
CLINICA CHIMICA ACTA, 2024, 558 : 26 - 27
[16] Evaluation of Xpert MTB/RIF Ultra assay for detection of Mycobacterium tuberculosis and rifampicin resistance
Huang, Wenjie
Lee, Melody Kee Tai
Sin, Amanda Teo Kai
Nazari, Reyan Shah
Chua, Syn Yu
Sng, Li-Hwei
PATHOLOGY, 2023, 55 (05) : 688 - 697
[17] The new Xpert Mycobacterium tuberculosis/rifampicin (MTB/Rif) Ultra assay in comparison to Xpert MTB/Rif assay for diagnosis of tuberculosis in children and adolescents
Kaur, Harveen
Guglani, Vishal
Singhal, Lipika
Randev, Shivani
Kumar, Pankaj
Gupta, Varsha
JOURNAL OF TROPICAL PEDIATRICS, 2023, 70 (01)
[18] RIFAMPICIN-RESISTANT MYCOBACTERIUM-TUBERCULOSIS
WELTMAN, AC
RIGHI, SP
DIFERDINANDO, GT
JOVELL, RJ
DRISCOLL, JR
LANCET, 1995, 345 (8963): : 1513 - 1513
[19] Activity of rifampicin and linezolid combination in Mycobacterium tuberculosis
Maltempe, Flaviane Granero
Caleffi-Ferracioli, Katiany Rizzieri
Ribeiro do Amaral, Renata Claro
Demitto, Fernanda de Oliveira
Dias Siqueira, Vera Lucia
de Lima Scodro, Regiane Bertin
Hirata, Mario Hiroyuki
Pavan, Fernando Rogerio
Cardoso, Rosilene Fressatti
TUBERCULOSIS, 2017, 104 : 24 - 29
[20] Rifampicin resistant Mycobacterium tuberculosis in Vietnam: Comment
Daungsupawong, Hineptch
Wiwanitkit, Viroj
JOURNAL OF CLINICAL TUBERCULOSIS AND OTHER MYCOBACTERIAL DISEASES, 2024, 36

← 1 2 3 4 5 →